-
公开(公告)号:US12109271B2
公开(公告)日:2024-10-08
申请号:US17257731
申请日:2019-07-03
IPC分类号: A61K47/59 , A61K31/203 , A61K31/436 , A61K31/593 , A61K38/18 , A61K38/19 , A61K38/20 , A61K39/00 , A61P25/00
CPC分类号: A61K47/593 , A61K31/203 , A61K31/436 , A61K31/593 , A61K38/1841 , A61K38/1866 , A61K38/193 , A61K38/2066 , A61K39/0008 , A61P25/00
摘要: Provided are a dual microparticle system to treat Multiple Sclerosis, the system comprising phagocytosable and non-phagocytosable microparticles for delivery of at least one antigen, at least one immunomodulatory agent, at least one immunosuppressive agent and at least one chemoattractant to a subject suffering from Multiple Sclerosis to generate tolerogenic dendritic cells in the subject and treat the Multiple Sclerosis.